Alex Hs Harris1, Alfred C Kuo2, Thomas Bowe3, Shalini Gupta3, David Nordin4, Nicholas J Giori5. 1. Center for Innovation to Implementation, VA Palo Alto Health Care System, Palo Alto, CA; Department of Surgery, Stanford -Surgical Policy Improvement Research and Education Center, Stanford University School of Medicine, Stanford, CA. 2. San Francisco Veterans Affairs Medical Center, University of California, San Francisco, CA. 3. Center for Innovation to Implementation, VA Palo Alto Health Care System, Palo Alto, CA. 4. Minneapolis Veterans Affairs Medical Center, Minneapolis, MN. 5. Center for Innovation to Implementation, VA Palo Alto Health Care System, Palo Alto, CA; Department of Orthopedic Surgery, Stanford University School of Medicine, Stanford, CA.
Abstract
BACKGROUND: Statistical models to preoperatively predict patients' risk of death and major complications after total joint arthroplasty (TJA) could improve the quality of preoperative management and informed consent. Although risk models for TJA exist, they have limitations including poor transparency and/or unknown or poor performance. Thus, it is currently impossible to know how well currently available models predict short-term complications after TJA, or if newly developed models are more accurate. We sought to develop and conduct cross-validation of predictive risk models, and report details and performance metrics as benchmarks. METHODS: Over 90 preoperative variables were used as candidate predictors of death and major complications within 30 days for Veterans Health Administration patients with osteoarthritis who underwent TJA. Data were split into 3 samples-for selection of model tuning parameters, model development, and cross-validation. C-indexes (discrimination) and calibration plots were produced. RESULTS: A total of 70,569 patients diagnosed with osteoarthritis who received primary TJA were included. C-statistics and bootstrapped confidence intervals for the cross-validation of the boosted regression models were highest for cardiac complications (0.75; 0.71-0.79) and 30-day mortality (0.73; 0.66-0.79) and lowest for deep vein thrombosis (0.59; 0.55-0.64) and return to the operating room (0.60; 0.57-0.63). CONCLUSIONS: Moderately accurate predictive models of 30-day mortality and cardiac complications after TJA in Veterans Health Administration patients were developed and internally cross-validated. By reporting model coefficients and performance metrics, other model developers can test these models on new samples and have a procedure and indication-specific benchmark to surpass. Published by Elsevier Inc.
BACKGROUND: Statistical models to preoperatively predict patients' risk of death and major complications after total joint arthroplasty (TJA) could improve the quality of preoperative management and informed consent. Although risk models for TJA exist, they have limitations including poor transparency and/or unknown or poor performance. Thus, it is currently impossible to know how well currently available models predict short-term complications after TJA, or if newly developed models are more accurate. We sought to develop and conduct cross-validation of predictive risk models, and report details and performance metrics as benchmarks. METHODS: Over 90 preoperative variables were used as candidate predictors of death and major complications within 30 days for Veterans Health Administration patients with osteoarthritis who underwent TJA. Data were split into 3 samples-for selection of model tuning parameters, model development, and cross-validation. C-indexes (discrimination) and calibration plots were produced. RESULTS: A total of 70,569 patients diagnosed with osteoarthritis who received primary TJA were included. C-statistics and bootstrapped confidence intervals for the cross-validation of the boosted regression models were highest for cardiac complications (0.75; 0.71-0.79) and 30-day mortality (0.73; 0.66-0.79) and lowest for deep vein thrombosis (0.59; 0.55-0.64) and return to the operating room (0.60; 0.57-0.63). CONCLUSIONS: Moderately accurate predictive models of 30-day mortality and cardiac complications after TJA in Veterans Health Administration patients were developed and internally cross-validated. By reporting model coefficients and performance metrics, other model developers can test these models on new samples and have a procedure and indication-specific benchmark to surpass. Published by Elsevier Inc.
Authors: Yi Mu; Jonathan R Edwards; Teresa C Horan; Sandra I Berrios-Torres; Scott K Fridkin Journal: Infect Control Hosp Epidemiol Date: 2011-09-01 Impact factor: 3.254
Authors: Ryan P Merkow; Bruce L Hall; Mark E Cohen; Justin B Dimick; Edward Wang; Warren B Chow; Clifford Y Ko; Karl Y Bilimoria Journal: J Am Coll Surg Date: 2012-03-21 Impact factor: 6.113
Authors: Harvey J Murff; Fern FitzHenry; Michael E Matheny; Nancy Gentry; Kristen L Kotter; Kimberly Crimin; Robert S Dittus; Amy K Rosen; Peter L Elkin; Steven H Brown; Theodore Speroff Journal: JAMA Date: 2011-08-24 Impact factor: 56.272
Authors: Alex H S Harris; Rachelle Reeder; Laura Ellerbe; Katharine A Bradley; Anna D Rubinsky; Nicholas J Giori Journal: J Bone Joint Surg Am Date: 2011-02-16 Impact factor: 5.284
Authors: Frances Weaver; Denise Hynes; William Hopkinson; Richard Wixson; Shukri Khuri; Jennifer Daley; William G Henderson Journal: J Arthroplasty Date: 2003-09 Impact factor: 4.757
Authors: Alex H S Harris; Alfred C Kuo; Yingjie Weng; Amber W Trickey; Thomas Bowe; Nicholas J Giori Journal: Clin Orthop Relat Res Date: 2019-02 Impact factor: 4.176
Authors: Alex H S Harris; Alfred C Kuo; Kevin J Bozic; Edmund Lau; Thomas Bowe; Shalini Gupta; Nicholas J Giori Journal: Clin Orthop Relat Res Date: 2018-09 Impact factor: 4.176
Authors: Kevin T Pritchard; Ickpyo Hong; James S Goodwin; Jordan R Westra; Yong-Fang Kuo; Kenneth J Ottenbacher Journal: J Am Med Dir Assoc Date: 2020-10-09 Impact factor: 7.802
Authors: Lilisbeth Perestelo-Pérez; Yolanda Álvarez-Pérez; Amado Rivero-Santana; Vanesa Ramos-García; Andrea Duarte-Díaz; Alezandra Torres-Castaño; Ana Toledo-Chávarri; Mario Herrera-Perez; José Luis País-Brito; José Carlos Del Castillo; José Ramón Vázquez; Carola Orrego; Pedro Serrano-Aguilar Journal: Trials Date: 2020-08-24 Impact factor: 2.279
Authors: Seshadri C Mudumbai; Suzann Pershing; Thomas Bowe; Robin N Kamal; Erika D Sears; Andrea K Finlay; Dan Eisenberg; Mary T Hawn; Yingjie Weng; Amber W Trickey; Edward R Mariano; Alex H S Harris Journal: BMC Health Serv Res Date: 2019-11-21 Impact factor: 2.655